Proparacaine Hydrochloride Ophthalmic Solution USP, 0.5%

Manufacturer
NuCare Pharmaceuticals,Inc.
Effective date
2021-02-17
Label type
HUMAN PRESCRIPTION DRUG LABEL
Version
3
Source
legacy-cache
Hydrated at
2026-08-01 22:52:03

Label at a glance#

ProductProparacaine Hydrochloride
Active ingredientPROPARACAINE HYDROCHLORIDE
Label structure11 sections

Indications and uses

Proparacaine hydrochloride ophthalmic solution is indicated for procedures in which a topical ophthalmic anesthetic is indicated: corneal anesthesia of short duration, e.g. tonometry, gonioscopy, removal of corneal foreign bodies, and for short corneal and conjunctival procedures.

Dosage and administration

Usual Dosage: Removal of foreign bodies and sutures, and for tonometry: 1 to 2 drops (in single instillations) in each eye before operating. Short corneal and conjunctival procedures: 1 drop in each eye every 5 to 10 minutes for 5 to 7 doses. NOTE: Proparacaine hydrochloride ophthalmic solution should be clear to straw-color. If the solution becomes darker, discard the solution.

Label contents#

Full prescribing information#

DESCRIPTION

DESCRIPTION SECTION

Proparacaine hydrochloride ophthalmic solution 0.5% is a topical local anesthetic for ophthalmic use. The active ingredient is represented by the structural formula:

Established name: Proparacaine Hydrochloride

Chemical name: Benzoic acid, 3-amino-4-propoxy-,2-(diethylamino) ethyl ester, monohydrochloride.

chemical
chemical

Molecular Weight: 330.85

Each mL contains: Active: proparacaine hydrochloride 5mg 0.5%. Preservative: benzalkonium chloride (0.01%). Inactives: glycerin; and purified water. The pH may be adjusted with hydrochloric acid and/or sodium hydroxide.

CLINICAL PHARMACOLOGY

CLINICAL PHARMACOLOGY SECTION

Proparacaine hydrochloride ophthalmic solution is a rapidly-acting topical anesthetic, with induced anesthesia lasting approximately 10-20 minutes.

INDICATIONS AND USAGE

INDICATIONS & USAGE SECTION

Proparacaine hydrochloride ophthalmic solution is indicated for procedures in which a topical ophthalmic anesthetic is indicated: corneal anesthesia of short duration, e.g. tonometry, gonioscopy, removal of corneal foreign bodies, and for short corneal and conjunctival procedures.

CONTRAINDICATIONS

CONTRAINDICATIONS SECTION

Proparacaine hydrochloride ophthalmic solution should be considered contraindicated in patients with known hypersensitivity to any of the ingredients of this preparation.

WARNINGS

WARNINGS SECTION

NOT FOR INJECTION - FOR TOPICAL OPHTHALMIC USE ONLY. Prolonged use of a topical ocular anesthetic is not recommended. It may produce permanent corneal opacification with accompanying visual loss.

PRECAUTIONS

PRECAUTIONS SECTION

Carcinogenesis, Mutagenesis, Impairment of Fertility

CARCINOGENESIS & MUTAGENESIS & IMPAIRMENT OF FERTILITY SECTION

Long-term studies in animals have not been performed to evaluate carcinogenic potential, mutagenicity, or possible impairment of fertility in males or females.

Pregnancy

PREGNANCY SECTION

Pregnancy Category C: Animal reproduction studies have not been conducted with proparacaine hydrochloride ophthalmic solution 0.5%. It is also not known whether proparacaine hydrochloride can cause fetal harm when administered to a pregnant woman or can affect reproduction capacity. Proparacaine hydrochloride should be administered to a pregnant woman only if clearly needed.

Nursing Mothers

NURSING MOTHERS SECTION

It is not known whether this drug is excreted in human milk. Because many drugs are excreted in human milk, caution should be exercised when proparacaine hydrochloride is administered to a nursing woman.

Pediatric Use

PEDIATRIC USE SECTION

Safety and effectiveness of proparacaine hydrochloride ophthalmic solution in pediatric patients have been established. Use of proparacaine hydrochloride is supported by evidence from adequate and well-controlled studies in adults and children over the age of twelve, and safety information in neonates and other pediatric patients.

Geriatric Use

GERIATRIC USE SECTION

No overall clinical differences in safety or effectiveness have been observed between the elderly and other adult patients

ADVERSE REACTIONS

ADVERSE REACTIONS SECTION

Occasional temporary stinging, burning and conjunctival redness may occur with the use of proparacaine. A rare, severe, immediate-type, apparently hyperallergic corneal reaction characterized by acute, intense and diffuse epithelial keratitis, a gray, ground glass appearance, sloughing of large areas of necrotic epithelium, corneal filaments and, sometimes, iritis with descemetitis has been reported.

Allergic contact dermatitis from proparacaine with drying and fissuring of the fingertips has also been reported.

DOSAGE AND ADMINISTRATION

DOSAGE & ADMINISTRATION SECTION

Usual Dosage: Removal of foreign bodies and sutures, and for tonometry: 1 to 2 drops (in single instillations) in each eye before operating.

Short corneal and conjunctival procedures: 1 drop in each eye every 5 to 10 minutes for 5 to 7 doses.

NOTE: Proparacaine hydrochloride ophthalmic solution should be clear to straw-color. If the solution becomes darker, discard the solution.

HOW SUPPLIED

HOW SUPPLIED SECTION

Proparacaine hydrochloride ophthalmic solution 0.5% is supplied in 15 mL DROP-TAINER* dispensers.

NDC 68071-4701-5

Storage: Bottle must be stored in unit carton to protect contents from light. Store bottles under refrigeration at 2° - 8°C (36° - 46°F).

Rx Only

SPL UNCLASSIFIED SECTION

To report SUSPECTED ADVERSE REACTIONS, contact Sandoz Inc., at 1-800-525-8747 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.

*DROP-TAINER is a registered trademark of Alcon Research, Ltd.

Rev. June 2012

SANDOZ

Manufactured by
Alcon Laboratories, Inc.
Fort Worth, Texas 76134 for
Sandoz Inc.
Princeton, NJ 08540
Printed in USA

9007253-1011

PRINCIPAL DISPLAY PANEL

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

pdppdp

FDA-Initiated Inactive NDC Indexing#

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
61314-016-01ML - Milliliter61314-016180896a3-8756-447b-b1c1-c6fe81b7539512012-07-24

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 7 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
68071-470168071-4701-5
61314-016

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 6 matching rows.

Source Document#

Source XML

Orange Book application contexts#

All distinct exact application/product contexts derived from this label’s complete NDC list are paginated below.

Orange Book application contexts page 1 of 1 · 1 matching rows.

Source provenance: Browse the complete Orange Book source catalog · source snapshot 43.

Orange Book products#

Current product rows page 1 of 1 · 1 matching rows.

Application-product, Trade name, Ingredient table
Application-productTrade nameIngredientStrengthDosage form / routeTE codesRLD / RSApproval date
A080027-001ALCAINEPROPARACAINE HYDROCHLORIDE0.5%SOLUTION/DROPS / OPHTHALMICATApproved before 1982

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 1 matching rows.

Application-product, TE code table
Application-productTE code
A080027-001AT

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 2 · 43 observed states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTrade nameStrengthDosage form / routeProduct TE source textRLD / RSApproval dateSource SHA-256
2026-09-14 22:38:342026-08A080027-001ALCAINE0.5%SOLUTION/DROPS / OPHTHALMICATApproved before 198284e616aacf4f…
2026-08-18 06:07:402026-07A080027-001ALCAINE0.5%SOLUTION/DROPS / OPHTHALMICATApproved before 1982caaa826d4ba7…
2026-02-19 14:30 UTC2026-02A080027-001ALCAINE0.5%SOLUTION/DROPS / OPHTHALMICATApproved before 1982011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A080027-001ALCAINE0.5%SOLUTION/DROPS / OPHTHALMICATApproved before 198231067a03dcf5…
2025-08-23 18:47 UTC2025-08A080027-001ALCAINE0.5%SOLUTION/DROPS / OPHTHALMICATApproved before 19826a471c1ec25d…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03A080027-001ALCAINE0.5%SOLUTION/DROPS / OPHTHALMICATApproved before 1982fd3edfee7708…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02A080027-001ALCAINE0.5%SOLUTION/DROPS / OPHTHALMICATApproved before 1982b8a1b40f171c…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01A080027-001ALCAINE0.5%SOLUTION/DROPS / OPHTHALMICATApproved before 198203ed91905a0d…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12A080027-001ALCAINE0.5%SOLUTION/DROPS / OPHTHALMICATApproved before 19822680178bc6a6…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09A080027-001ALCAINE0.5%SOLUTION/DROPS / OPHTHALMICATApproved before 19825bbf6a4d5a75…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11A080027-001ALCAINE0.5%SOLUTION/DROPS / OPHTHALMICATApproved before 1982d8e5a09893c0…
2024-10-29 15:01 UTC2024-10A080027-001ALCAINE0.5%SOLUTION/DROPS / OPHTHALMICATApproved before 1982d06236e962d9…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08A080027-001ALCAINE0.5%SOLUTION/DROPS / OPHTHALMICATApproved before 198279d66fd596c7…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07A080027-001ALCAINE0.5%SOLUTION/DROPS / OPHTHALMICATApproved before 1982301d65b070ca…
2024-06-18 03:08 UTC · 5 captures of this ZIP2024-06A080027-001ALCAINE0.5%SOLUTION/DROPS / OPHTHALMICATApproved before 19821e350fbaab3a…
2024-05-31 18:47 UTC2024-05A080027-001ALCAINE0.5%SOLUTION/DROPS / OPHTHALMICATApproved before 19828072bd15b7f6…
2022-06-29 02:47 UTC · 2 captures of this ZIP2022-06A080027-001ALCAINE0.5%SOLUTION/DROPS / OPHTHALMICATApproved before 19825c6f7cd8ea54…
2022-04-08 23:34 UTC2022-04A080027-001ALCAINE0.5%SOLUTION/DROPS / OPHTHALMICATApproved before 19825d02ea3f76ae…
2022-04-04 05:41 UTC2022-04A080027-001ALCAINE0.5%SOLUTION/DROPS / OPHTHALMICATApproved before 19824b0b4de00fa7…
2019-12-13 00:20 UTC2019-12A080027-001ALCAINE0.5%SOLUTION/DROPS / OPHTHALMICATApproved before 198274a2ff9319b5…
2022-03-09 01:35 UTC2022-03A080027-001ALCAINE0.5%SOLUTION/DROPS / OPHTHALMICATApproved before 1982bb7c543d1eb4…
2021-12-28 21:50 UTC2021-12A080027-001ALCAINE0.5%SOLUTION/DROPS / OPHTHALMICATApproved before 1982782e0a99824c…
2021-05-05 16:15 UTC · 3 captures of this ZIP2021-05A080027-001ALCAINE0.5%SOLUTION/DROPS / OPHTHALMICATApproved before 198287673890dc5c…
2021-03-12 10:30 UTC2021-03A080027-001ALCAINE0.5%SOLUTION/DROPS / OPHTHALMICATApproved before 19825aa47cf7b7d7…
2020-12-22 03:56 UTC2020-12A080027-001ALCAINE0.5%SOLUTION/DROPS / OPHTHALMICATApproved before 19828869cabd3fbd…
2020-11-12 02:37 UTC2020-11A080027-001ALCAINE0.5%SOLUTION/DROPS / OPHTHALMICATApproved before 1982c0c555d07b60…
2019-12-14 00:12 UTC2019-12A080027-001ALCAINE0.5%SOLUTION/DROPS / OPHTHALMICATApproved before 19823f01610625f2…
2019-09-15 20:21 UTC2019-09A080027-001ALCAINE0.5%SOLUTION/DROPS / OPHTHALMICATApproved before 1982b00525d2431f…
2019-07-19 19:46 UTC2019-07A080027-001ALCAINE0.5%SOLUTION/DROPS / OPHTHALMICATApproved before 1982ea99ee380514…
2024-03-16 18:09 UTC · 4 captures of this ZIP2024-03A080027-001ALCAINE0.5%SOLUTION/DROPS / OPHTHALMICATApproved before 19826a51e52b5d6a…
2024-02-18 07:12 UTC2024-02A080027-001ALCAINE0.5%SOLUTION/DROPS / OPHTHALMICATApproved before 19821c564ffb4f44…
2023-12-20 04:57 UTC2023-12A080027-001ALCAINE0.5%SOLUTION/DROPS / OPHTHALMICATApproved before 1982ea1830bbd6c7…
2023-11-28 05:40 UTC · 2 captures of this ZIP2023-11A080027-001ALCAINE0.5%SOLUTION/DROPS / OPHTHALMICATApproved before 1982a72a2bbeb626…
2023-10-25 00:34 UTC · 2 captures of this ZIP2023-10A080027-001ALCAINE0.5%SOLUTION/DROPS / OPHTHALMICATApproved before 19829b2671bbb829…
2023-07-15 15:27 UTC · 2 captures of this ZIP2023-07A080027-001ALCAINE0.5%SOLUTION/DROPS / OPHTHALMICATApproved before 1982a67488948f0b…
2023-06-13 01:57 UTC · 3 captures of this ZIP2023-06A080027-001ALCAINE0.5%SOLUTION/DROPS / OPHTHALMICATApproved before 19823f0d92c62455…
2023-05-13 08:27 UTC2023-05A080027-001ALCAINE0.5%SOLUTION/DROPS / OPHTHALMICATApproved before 1982053a50430f4f…
2023-01-26 05:58 UTC2023-01A080027-001ALCAINE0.5%SOLUTION/DROPS / OPHTHALMICATApproved before 19823bdfa0b2c4d7…
2022-11-12 20:34 UTC · 5 captures of this ZIP2022-11A080027-001ALCAINE0.5%SOLUTION/DROPS / OPHTHALMICATApproved before 19823a93d1ddd44b…
2022-10-28 04:53 UTC2022-10A080027-001ALCAINE0.5%SOLUTION/DROPS / OPHTHALMICATApproved before 1982f41ea6bd6efb…

Observed Orange Book normalized TE history#

Normalized TE history page 1 of 2 · 43 observed states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTE codeOrderSource SHA-256
2026-09-14 22:38:342026-08A080027-001AT184e616aacf4f…
2026-08-18 06:07:402026-07A080027-001AT1caaa826d4ba7…
2026-02-19 14:30 UTC2026-02A080027-001AT1011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A080027-001AT131067a03dcf5…
2025-08-23 18:47 UTC2025-08A080027-001AT16a471c1ec25d…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03A080027-001AT1fd3edfee7708…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02A080027-001AT1b8a1b40f171c…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01A080027-001AT103ed91905a0d…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12A080027-001AT12680178bc6a6…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09A080027-001AT15bbf6a4d5a75…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11A080027-001AT1d8e5a09893c0…
2024-10-29 15:01 UTC2024-10A080027-001AT1d06236e962d9…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08A080027-001AT179d66fd596c7…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07A080027-001AT1301d65b070ca…
2024-06-18 03:08 UTC · 5 captures of this ZIP2024-06A080027-001AT11e350fbaab3a…
2024-05-31 18:47 UTC2024-05A080027-001AT18072bd15b7f6…
2022-06-29 02:47 UTC · 2 captures of this ZIP2022-06A080027-001AT15c6f7cd8ea54…
2022-04-08 23:34 UTC2022-04A080027-001AT15d02ea3f76ae…
2022-04-04 05:41 UTC2022-04A080027-001AT14b0b4de00fa7…
2019-12-13 00:20 UTC2019-12A080027-001AT174a2ff9319b5…
2022-03-09 01:35 UTC2022-03A080027-001AT1bb7c543d1eb4…
2021-12-28 21:50 UTC2021-12A080027-001AT1782e0a99824c…
2021-05-05 16:15 UTC · 3 captures of this ZIP2021-05A080027-001AT187673890dc5c…
2021-03-12 10:30 UTC2021-03A080027-001AT15aa47cf7b7d7…
2020-12-22 03:56 UTC2020-12A080027-001AT18869cabd3fbd…
2020-11-12 02:37 UTC2020-11A080027-001AT1c0c555d07b60…
2019-12-14 00:12 UTC2019-12A080027-001AT13f01610625f2…
2019-09-15 20:21 UTC2019-09A080027-001AT1b00525d2431f…
2019-07-19 19:46 UTC2019-07A080027-001AT1ea99ee380514…
2024-03-16 18:09 UTC · 4 captures of this ZIP2024-03A080027-001AT16a51e52b5d6a…
2024-02-18 07:12 UTC2024-02A080027-001AT11c564ffb4f44…
2023-12-20 04:57 UTC2023-12A080027-001AT1ea1830bbd6c7…
2023-11-28 05:40 UTC · 2 captures of this ZIP2023-11A080027-001AT1a72a2bbeb626…
2023-10-25 00:34 UTC · 2 captures of this ZIP2023-10A080027-001AT19b2671bbb829…
2023-07-15 15:27 UTC · 2 captures of this ZIP2023-07A080027-001AT1a67488948f0b…
2023-06-13 01:57 UTC · 3 captures of this ZIP2023-06A080027-001AT13f0d92c62455…
2023-05-13 08:27 UTC2023-05A080027-001AT1053a50430f4f…
2023-01-26 05:58 UTC2023-01A080027-001AT13bdfa0b2c4d7…
2022-11-12 20:34 UTC · 5 captures of this ZIP2022-11A080027-001AT13a93d1ddd44b…
2022-10-28 04:53 UTC2022-10A080027-001AT1f41ea6bd6efb…

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 2 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
1ab9b66d-5795-5080-e063-6394a90a3f947ef96b81-e1b5-6c7b-e053-2991aa0aedd32024-06-12Warnings, Adverse reactionsExact identifier
spl set id: 7ef96b81-e1b5-6c7b-e053-2991aa0aedd3
Proparacaine HydrochloridePROPARACAINE HYDROCHLORIDESandoz Inc.447a2a64-0507-4fe8-bb44-cc36c39161512022-06-29Warnings, Adverse reactionsExact identifier
ndc (product): 61314-016

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.